Compounding Pharmacy Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4101470
- 109 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Compounding Pharmacy market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Compounding Pharmacy market segmented into
Adult
Pharmaceutical application alteration (PAA)
Currently unavailable pharmaceutical manufacturing (CUPM)
Pharmaceutical dosage alteration (PDA)
Specialized animal pharmaceutical manufacturing (SAPM)
Based on the end-use, the global Compounding Pharmacy market classified into
Adult
Paediatric
Geriatric
Veterinary
Based on geography, the global Compounding Pharmacy market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Fagron
Wedgewood Pharma
CAPS
Fresenius Kabi
PharMEDium Services
Cantrell Drug
Advanced Pharma
Dougherty's Pharmacy
Institutional Pharmacy Solutions
Lorraine's Pharmacy
Village Compounding Pharmacy
Triangle Compounding Pharmacy
Olympia Pharmacy
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL COMPOUNDING PHARMACY INDUSTRY
2.1 Summary about Compounding Pharmacy Industry
2.2 Compounding Pharmacy Market Trends
2.2.1 Compounding Pharmacy Production & Consumption Trends
2.2.2 Compounding Pharmacy Demand Structure Trends
2.3 Compounding Pharmacy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pharmaceutical ingredient alteration (PIA)
4.2.2 Pharmaceutical application alteration (PAA)
4.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
4.2.4 Pharmaceutical dosage alteration (PDA)
4.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Adult
4.3.2 Paediatric
4.3.3 Geriatric
4.3.4 Veterinary
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pharmaceutical ingredient alteration (PIA)
5.2.2 Pharmaceutical application alteration (PAA)
5.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
5.2.4 Pharmaceutical dosage alteration (PDA)
5.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Adult
5.3.2 Paediatric
5.3.3 Geriatric
5.3.4 Veterinary
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pharmaceutical ingredient alteration (PIA)
6.2.2 Pharmaceutical application alteration (PAA)
6.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
6.2.4 Pharmaceutical dosage alteration (PDA)
6.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Adult
6.3.2 Paediatric
6.3.3 Geriatric
6.3.4 Veterinary
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pharmaceutical ingredient alteration (PIA)
7.2.2 Pharmaceutical application alteration (PAA)
7.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
7.2.4 Pharmaceutical dosage alteration (PDA)
7.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Adult
7.3.2 Paediatric
7.3.3 Geriatric
7.3.4 Veterinary
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pharmaceutical ingredient alteration (PIA)
8.2.2 Pharmaceutical application alteration (PAA)
8.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
8.2.4 Pharmaceutical dosage alteration (PDA)
8.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Adult
8.3.2 Paediatric
8.3.3 Geriatric
8.3.4 Veterinary
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pharmaceutical ingredient alteration (PIA)
9.2.2 Pharmaceutical application alteration (PAA)
9.2.3 Currently unavailable pharmaceutical manufacturing (CUPM)
9.2.4 Pharmaceutical dosage alteration (PDA)
9.2.5 Specialized animal pharmaceutical manufacturing (SAPM)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Adult
9.3.2 Paediatric
9.3.3 Geriatric
9.3.4 Veterinary
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Fagron
10.1.2 Wedgewood Pharma
10.1.3 CAPS
10.1.4 Fresenius Kabi
10.1.5 PharMEDium Services
10.1.6 Cantrell Drug
10.1.7 Advanced Pharma
10.1.8 Dougherty's Pharmacy
10.1.9 Institutional Pharmacy Solutions
10.1.10 Lorraine's Pharmacy
10.1.11 Village Compounding Pharmacy
10.1.12 Triangle Compounding Pharmacy
10.1.13 Olympia Pharmacy
10.2 Compounding Pharmacy Sales Date of Major Players (2017-2020e)
10.2.1 Fagron
10.2.2 Wedgewood Pharma
10.2.3 CAPS
10.2.4 Fresenius Kabi
10.2.5 PharMEDium Services
10.2.6 Cantrell Drug
10.2.7 Advanced Pharma
10.2.8 Dougherty's Pharmacy
10.2.9 Institutional Pharmacy Solutions
10.2.10 Lorraine's Pharmacy
10.2.11 Village Compounding Pharmacy
10.2.12 Triangle Compounding Pharmacy
10.2.13 Olympia Pharmacy
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Compounding Pharmacy Product Type Overview
2.Table Compounding Pharmacy Product Type Market Share List
3.Table Compounding Pharmacy Product Type of Major Players
4.Table Brief Introduction of Fagron
5.Table Brief Introduction of Wedgewood Pharma
6.Table Brief Introduction of CAPS
7.Table Brief Introduction of Fresenius Kabi
8.Table Brief Introduction of PharMEDium Services
9.Table Brief Introduction of Cantrell Drug
10.Table Brief Introduction of Advanced Pharma
11.Table Brief Introduction of Dougherty's Pharmacy
12.Table Brief Introduction of Institutional Pharmacy Solutions
13.Table Brief Introduction of Lorraine's Pharmacy
14.Table Brief Introduction of Village Compounding Pharmacy
15.Table Brief Introduction of Triangle Compounding Pharmacy
16.Table Brief Introduction of Olympia Pharmacy
17.Table Products & Services of Fagron
18.Table Products & Services of Wedgewood Pharma
19.Table Products & Services of CAPS
20.Table Products & Services of Fresenius Kabi
21.Table Products & Services of PharMEDium Services
22.Table Products & Services of Cantrell Drug
23.Table Products & Services of Advanced Pharma
24.Table Products & Services of Dougherty's Pharmacy
25.Table Products & Services of Institutional Pharmacy Solutions
26.Table Products & Services of Lorraine's Pharmacy
27.Table Products & Services of Village Compounding Pharmacy
28.Table Products & Services of Triangle Compounding Pharmacy
29.Table Products & Services of Olympia Pharmacy
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Compounding Pharmacy Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Compounding Pharmacy Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Compounding Pharmacy Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Compounding Pharmacy Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
